Uri Weinberg

Uri Weinberg

Chief Medical and Innovation OfficeratNovoCure· In proxies 2024–2025

Pay in FY2025-18% from the year before · NovoCure stock -56.6% the same year

Uri Weinberg was paid $4.2M in FY2025 (Dec), down 18%. NovoCure stock fell 56.6% that year.

Pay$100 in the stock at the end of FY23 → $87
Pay is from the Summary Compensation Table of each NovoCure proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NovoCurePublic company · 2 yr
    • Chief Medical and Innovation Officer2024 – Present · 2 yrStock in role +5%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?